Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Carcinoma, Ovarian Epithelial × poly ICLC × 1 year × Clear all

Sponsor

Conditions

Pancreatic Neoplasms 5 Melanoma 4 Glioblastoma 3 Carcinoma 3 Fibrolamellar hepatocellular carcinoma 2 Colorectal Neoplasms 2 Colonic Neoplasms 2 Carcinoma, Non-Small-Cell Lung 2 Carcinoma, Merkel Cell 2 Breast Neoplasms 2 Uterine Cervical Neoplasms 1 Urinary Bladder Neoplasms 1 Triple Negative Breast Neoplasms 1 Thrombocythemia, Essential 1 Stomach Neoplasms 1 Smoldering Multiple Myeloma 1 Small Cell Lung Carcinoma 1 Sarcoma 1 Prostatic Neoplasms 1 Primary Myelofibrosis 1 Ovarian Neoplasms 1 Osteosarcoma 1 Neoplasms, Squamous Cell 1 Neoplasms, Plasma Cell 1 Neoplasms 1 Neoplasm Metastasis 1 Myelodysplastic Syndromes 1 Lung Neoplasms 1 Liver Neoplasms 1 Leukemia, Myelomonocytic, Chronic 1

Interventions

Paclitaxel 12 Carboplatin 8 pembrolizumab 7 Bevacizumab 7 liposomal doxorubicin 5 Nivolumab 5 mirvetuximab soravtansine 4 Topotecan 4 ribociclib 3 olaparib 3 Fulvestrant 3 Drug Therapy 3 rucaparib 2 pegfilgrastim 2 palbociclib 2 oregovomab 2 niraparib 2 fludarabine phosphate 2 fludarabine 2 Irinotecan 2 Hyperthermic Intraperitoneal Chemotherapy 2 Gemcitabine 2 Cyclophosphamide 2 Blood Specimen Collection 2 1-dodecylpyridoxal 2 trastuzumab deruxtecan 1 spartalizumab 1 sargramostim 1 sacituzumab govitecan 1 isoquercitrin 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡